Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 580
Book Description
FDA'S REGULATION OF ZOMAX: HEARINGS before a Subcommittee on Government Operations House of Representatives, 98th Congress.
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 580
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 580
Book Description
Signals from the Hill
Author: Christopher H. Foreman
Publisher: Yale University Press
ISBN: 9780300044102
Category : Political Science
Languages : en
Pages : 236
Book Description
Does Congress do a good job of overseeing the work of the important legislative agencies--the EPA, FDA, OSHA, and others--that it has established to protect the public from some of the risks of modern technology? Combining analysis and anecdote, Christopher H. Foreman, Jr. looks into the oversight tools available to Congress, the variety of interest groups involved, the kinds of issues that arise between agencies and congressional committees, and the personal networks that affect relations between them; and he suggests what Congress can and should do to improve the process of social regulation. "Foreman adds substantially to our understanding of the role played by oversight. . . . A solid contribution toward understanding the nature of day-to-day congressional oversight."--Burdett Loomis, Journal of Politics " This book] is presented clearly, free from jargon, whether academic or governmental. . . . A solid discussion of oversight."--Jan P. Vermeer, Perspective "This is a thoughtful, effectively organized, and well-written book. Those concerned with legislative oversight will find it highly useful."--Morris S. Ogul, University of Pittsburgh Winner of the 1989 D. B. Hardeman Prize given by the Lyndon Baines Johnson Library for the best book on Congress in the twentieth century
Publisher: Yale University Press
ISBN: 9780300044102
Category : Political Science
Languages : en
Pages : 236
Book Description
Does Congress do a good job of overseeing the work of the important legislative agencies--the EPA, FDA, OSHA, and others--that it has established to protect the public from some of the risks of modern technology? Combining analysis and anecdote, Christopher H. Foreman, Jr. looks into the oversight tools available to Congress, the variety of interest groups involved, the kinds of issues that arise between agencies and congressional committees, and the personal networks that affect relations between them; and he suggests what Congress can and should do to improve the process of social regulation. "Foreman adds substantially to our understanding of the role played by oversight. . . . A solid contribution toward understanding the nature of day-to-day congressional oversight."--Burdett Loomis, Journal of Politics " This book] is presented clearly, free from jargon, whether academic or governmental. . . . A solid discussion of oversight."--Jan P. Vermeer, Perspective "This is a thoughtful, effectively organized, and well-written book. Those concerned with legislative oversight will find it highly useful."--Morris S. Ogul, University of Pittsburgh Winner of the 1989 D. B. Hardeman Prize given by the Lyndon Baines Johnson Library for the best book on Congress in the twentieth century
Patent Extension Hearing
Author: United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Patents, Copyrights, and Trademarks
Publisher:
ISBN:
Category : Law
Languages : en
Pages : 496
Book Description
Publisher:
ISBN:
Category : Law
Languages : en
Pages : 496
Book Description
Granting Additional Market Exclusivity to the Drug Ansaid
Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment
Publisher:
ISBN:
Category : Business & Economics
Languages : en
Pages : 72
Book Description
Publisher:
ISBN:
Category : Business & Economics
Languages : en
Pages : 72
Book Description
Interim Report of the Activities of the House Committee on Government Operations
Author: United States. Congress. House. Committee on Government Operations
Publisher:
ISBN:
Category :
Languages : en
Pages : 820
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 820
Book Description
Science, Politics And The Pharmaceutical Industry
Author: John Abraham
Publisher: Taylor & Francis
ISBN: 1000951308
Category : Medical
Languages : en
Pages : 201
Book Description
Drug disasters from Thalidomide to Opren, and other less dramatic cases of drug injury, raise questions about whether the testing and control of medicines provides satisfactory protection for the public. In this revealing study, John Abrahan develops a theoretically challenging realist approach, in order to probe deeply into the work of scientists in the pharmaceutical industry and governmental drug regulatory authorities on both sides of the Atlantic. Through the examination of contemporary controversial case studies, he exposes how the commercial interest of drug manufacturers are consistently given the benefit of the scientific doubts about medicine safety and effectiveness, over and above the best interests of patients.; A highly original combination of philosophical rigour, historical sensitivity and empirical depth enables the "black box" of industrial and government science to be opened up to critical scrutiny much more than in previous social scientific study. All major aspects of drug testing and regulation are considered, including pre- clinical animal tests, clinical trials and postmarketing surveillance of adverse drug reactions. The author argues that drug regulators are too dependent on pharmaceutical industry resources and expertise, and too divorced from public accountability. The problem of corporate bias is particularly severe in the UK, where regulatory decisions about medicine safety are shrouded in greater secrecy than in the US.; Since the purpose of drug regulation should be to maximize the safety and effectiveness of medicines for patients, the public needs and deserves policies to counteract corporate bias in drug testing and evaluation. John Abraham's realist analysis provides a robust basis for policy interventions at the institutional and legislative levels. He proposes that corporate bias could be reduced by more extensive freedom of information, greater autonomy of government scientists from pharmaceutical industry, the development of independent drug testing by the regulatory authority, increased patient representation on regulatory committees, and more frequent and thorough oversight of regulatory performance by the legislature. This book should be of interest to anyone who cares about how medicines should be controlled in modern society. It should prove particularly rewarding for students and researchers in the sociology of science and technology, science and medicines policy, medical sociologists, the medical and pharmaceutical professions, and consumer organizations.
Publisher: Taylor & Francis
ISBN: 1000951308
Category : Medical
Languages : en
Pages : 201
Book Description
Drug disasters from Thalidomide to Opren, and other less dramatic cases of drug injury, raise questions about whether the testing and control of medicines provides satisfactory protection for the public. In this revealing study, John Abrahan develops a theoretically challenging realist approach, in order to probe deeply into the work of scientists in the pharmaceutical industry and governmental drug regulatory authorities on both sides of the Atlantic. Through the examination of contemporary controversial case studies, he exposes how the commercial interest of drug manufacturers are consistently given the benefit of the scientific doubts about medicine safety and effectiveness, over and above the best interests of patients.; A highly original combination of philosophical rigour, historical sensitivity and empirical depth enables the "black box" of industrial and government science to be opened up to critical scrutiny much more than in previous social scientific study. All major aspects of drug testing and regulation are considered, including pre- clinical animal tests, clinical trials and postmarketing surveillance of adverse drug reactions. The author argues that drug regulators are too dependent on pharmaceutical industry resources and expertise, and too divorced from public accountability. The problem of corporate bias is particularly severe in the UK, where regulatory decisions about medicine safety are shrouded in greater secrecy than in the US.; Since the purpose of drug regulation should be to maximize the safety and effectiveness of medicines for patients, the public needs and deserves policies to counteract corporate bias in drug testing and evaluation. John Abraham's realist analysis provides a robust basis for policy interventions at the institutional and legislative levels. He proposes that corporate bias could be reduced by more extensive freedom of information, greater autonomy of government scientists from pharmaceutical industry, the development of independent drug testing by the regulatory authority, increased patient representation on regulatory committees, and more frequent and thorough oversight of regulatory performance by the legislature. This book should be of interest to anyone who cares about how medicines should be controlled in modern society. It should prove particularly rewarding for students and researchers in the sociology of science and technology, science and medicines policy, medical sociologists, the medical and pharmaceutical professions, and consumer organizations.
Interim Report of the Activities of the House Committee on Government Operations, Ninety-eighth Congress, First Session, 1983
Author: United States. Congress. House. Committee on Government Operations
Publisher:
ISBN:
Category :
Languages : en
Pages : 200
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 200
Book Description
Science and Public Reason
Author: Sheila Jasanoff
Publisher: Routledge
ISBN: 0415524865
Category : Business & Economics
Languages : en
Pages : 306
Book Description
This book offers an empirically detailed, cross-nationally comparative account of the institutional logics and practices through which modern democratic governments construct public reason, that is, the forms of evidence and argument designed to persuade publics that legal and policy decisions are founded on reliable knowledge and expertise.
Publisher: Routledge
ISBN: 0415524865
Category : Business & Economics
Languages : en
Pages : 306
Book Description
This book offers an empirically detailed, cross-nationally comparative account of the institutional logics and practices through which modern democratic governments construct public reason, that is, the forms of evidence and argument designed to persuade publics that legal and policy decisions are founded on reliable knowledge and expertise.
Activities of the House Committee on Government Operations
Author: United States. Congress. House. Committee on Government Operations
Publisher:
ISBN:
Category :
Languages : en
Pages : 1044
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 1044
Book Description
House Reports
Author: 55th Congress. 2nd session
Publisher:
ISBN:
Category :
Languages : en
Pages : 1856
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 1856
Book Description